Tag: Drug Pricing

Legislation for Capping Prescription Drug Prices in State-Level Insurance Programs

Explore a new legislative model aimed at capping prescription drug prices, enhancing state-funded insurance programs through public feedback and savings validation.

CMS Requests Feedback on PBM Regulation Under CAA 2026

Explore how CMS is regulating Pharmacy Benefit Managers under CAA 2026, seeking feedback on compensation models and data reporting requirements. Act by July 20, 2026!

Regulatory Changes Impacting Medicaid and ACA: An Overview

Explore the regulatory changes under the Trump administration affecting Medicaid and ACA, with implications for coverage accessibility and health care costs.

Healthcare Legislation Updates and AI in Health Policy

Stay updated on the latest healthcare legislation, AI initiatives, and Medicare developments that shape health policy and patient care strategies.

Medicare Drug Price Negotiation: Proposed Rules and Industry Implications

Learn about the proposed Medicare drug price negotiation rule and its implications on the pharmaceutical industry and state regulations.

Federal Regulation Impacting Medicare Drug Pricing Strategies for 2029

Explore the proposed federal regulation for 2029 affecting Medicare pricing strategies for drugs. Understand the implications and upcoming changes in healthcare policy.

ASCO Updates 340B Drug Pricing Program Policy: Enhancing Oncology Care

Discover ASCO's updated 340B Drug Pricing Program policy aimed at enhancing access to oncology care for underserved populations.

Changes and Challenges in Medicare: What Beneficiaries Need to Know

Explore upcoming changes to Medicare, including premium hikes, drug pricing reforms, and telehealth expansions that benefit millions of beneficiaries.

Healthcare and Insurance Policies in Colorado's 8th Congressional District Primary

Explore how healthcare and insurance policies drive the Democratic primary in Colorado's 8th District. Learn about key issues and candidates' positions today.

Impact of PBM Ownership on Medicare Drug Costs

Discover how PBM ownership by insurers influences Medicare drug costs and understand the implications for pharmacies and patient access.